Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease
- 1 October 1999
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 93 (10) , 715-718
- https://doi.org/10.1016/s0954-6111(99)90038-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effects of Long-term Treatment With Corticosteroids in COPDChest, 1996
- Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEuropean Respiratory Journal, 1995
- Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.Thorax, 1993
- Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group.Thorax, 1992
- Steroid trials in the assessment of reversibility of air flow limitation: a survey of current clinical practice of chest physiciansRespiratory Medicine, 1991
- Oral Corticosteroid Therapy for Patients with Stable Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 1991
- Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.Thorax, 1990
- Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate.Thorax, 1990
- Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects.Thorax, 1987
- Corticosteroids in stable chronic obstructive pulmonary diseaseJournal of General Internal Medicine, 1987